Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus

This publication has 27 references indexed in Scilit:

• Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats.
  Circulation Research, 1989
• Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.
  Circulation Research, 1988
• The Effect of Etomoxir on Glucose Turnover and Recycling with [1-¹⁴C], [3-³H]-Glucose Tracer in Pigs
  Hormone and Metabolic Research, 1988
• Etomoxir
  Drugs of the Future, 1986
• Study on lipid metabolism in obesity diabetes
  Metabolism, 1984
• Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry
  Diabetologia, 1981
• Modifications of glucose storage and oxidation in nonobese diabetics, measured by continuous indirect calorimetry
  Diabetes, 1980
• Inhibition of mitochondrial carnitine palmitoyl transferase by 2-tetradecylglycidic acid (McN-3802) (Preliminary Communication)
  Life Sciences, 1980
• Carbohydrate and Lipid Oxidation in Normal and Diabetic Subjects
  Diabetes, 1977
• THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUS
  Published by Elsevier ,1963